2025 fourth_quarter Filing
Q4Income
$100K
Filed
January 20, 2026
Lobbying Activities
Health IssuesView all
Rare disease policy, drug approval process
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (2)
ms PATRICIA LOUISE DELOATCHE
Health Policy Director, Sen Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis
ABIGAIL CARROLL
Detailee to the Energy and Commerce Committee, U.S House of Representatives